Answers are grounded in this paper and cite their sources.
Rationale: Noonan syndrome (NS) is an autosomal dominant RASopathy caused by pathogenic variants in genes that regulate the rat sarcoma (RAS)/mitogen-activated protein kinase (MAPK) signaling pathway. Hearing impairment is increasingly recognized as part of the NS phenotype and may include sensorineural hearing loss of varying severity. Severe-to-profound sensorineural hearing loss may occasionally be an early presenting feature, particularly when other manifestations are subtle. Patient concerns: A male infant aged 2 months and 24 days was evaluated after repeatedly failing newborn hearing screening. Diagnoses: Diagnostic auditory brainstem response (ABR) testing was reported to indicate bilateral profound sensorineural hearing loss; however, the original ear-specific audiological data were unavailable for independent review. The infant had poor postnatal growth, with low weight and length for age, whereas head circumference remained within the World Health Organization (WHO) reference range. No characteristic facial features were identified at the initial assessment, and echocardiography revealed no structural cardiac abnormality. Genetic testing identified a heterozygous c.182A > G (p.Asp61Gly) variant in the protein tyrosine phosphatase non-receptor type 11 gene (PTPN11). Parental Sanger sequencing did not detect the variant in either parent, supporting a de novo origin. These findings were consistent with a diagnosis of Noonan syndrome. Interventions: The infant was referred to pediatric audiology for hearing-aid assessment and early auditory-verbal rehabilitation. According to parental report, hearing aids were subsequently fitted and auditory-verbal rehabilitation was initiated. Cochlear implant evaluation was under consideration because of the reported profound sensorineural hearing loss. The legal guardians also received genetic counseling regarding the diagnosis and inheritance of Noonan syndrome. Outcomes: At approximately 7 months of age, the family reported ongoing hearing-aid use and auditory-verbal rehabilitation, with subjective improvement in auditory responsiveness. Cochlear implant evaluation remained under consideration. No formal post-referral records or objective audiological outcome measures were available. Lessons: This case illustrates that Noonan syndrome can be diagnosed in early infancy when reported profound sensorineural hearing loss is accompanied by poor growth, even when typical facial and cardiac findings are not evident at the initial evaluation.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: